Abstract:IntroductionAntibiotic resistance has posed a serious challenge to global public health. With the increasing resistance emergence of E. coli and mortality caused by drug-resistant E. coli infections, it is urgent to develop novel antibiotics. MethodsBy high-throughput screening assay, we found a bioactive molecule, 0390 (6056-0390), which demonstrated antimicrobial effects against E. coli. The antimicrobial effects of 0390 alone or in combination with conventional antibiotics were assessed by scanning electron microscopy, transmission electron microscopy, drug combination assay, and growth inhibition assay. In addition, we investigated the antimicrobial efficacy in subcutaneous infection model in vivo Results0390 showed significant synergistic antimicrobial effects in combination with SPR741, a polymyxin B derivative, against E. coli standard strain and extensively drug-resistant (XDR) clinical isolates, and the combination exhibited good safety property in vitro. In addition, we demonstrated that the combinational treatment of 0390 and SPR741 exhibited a considerable antibacterial activity in vivo, and no tissue damage or other toxicity was observed after the therapeutic dose treatment. DiscussionTo confront the issue of the infectious diseases related to E. coli and its multidrug resistant strains, potential approaches, such as new antibacterial agents with different structures from conventional antibiotics and drug combinations, are urgently needed. In this study, we have determined the in vitro and in vivo antimicrobial potential of 0390 alone or in combination with SPR741, which might be used as a treatment option for E. coli related infections.

Antibacterial Activity and Mechanism of Coenzyme Q<sub>0</sub> Against <i>Escherichia coli</i>

Antimicrobial Activity and Antibiofilm Potential of Coenzyme Q0 against Salmonella Typhimurium

Inhibitory Effect of Coenzyme Q0 on the Growth of Staphylococcus Aureus

Antibacterial and antibiofilm activity of coenzyme Q0 against Vibrio parahaemolyticus

The Antimicrobial Activity of Coenzyme Q0 Against Planktonic and Biofilm Forms of Cronobacter Sakazakii.

Antimicrobial effect and stability of coenzyme Q0

Antibiofilm activity of coenzyme Q0 against Salmonella Typhimurium and its effect on adhesion–invasion and survival–replication

Effect of Coenzyme Q0 on Biofilm Formation and Attachment-Invasion Efficiency of Listeria Monocytogenes

Inhibition of Cronobacter sakazakii Biofilm Formation and Expression of Virulence Factors by Coenzyme Q<sub>0</sub>

Inhibition of Cronobacter Sakazakii Biofilm Formation and Expression of Virulence Factors by Coenzyme Q0

In Vitro Synergy of Nisin and Coenzyme Q0 Against Staphylococcus Aureus

Combined systems of different antibiotics with nano-CuO against Escherichia coli and the mechanisms involved

Antibacterial Mechanisms of Bacteriocin BM1157 Against Escherichia Coli and Cronobacter Sakazakii

Systematic And Molecular Basis Of The Antibacterial Action Of Quinoxaline 1,4-Di-N-Oxides Against Escherichia Coli

Antimicrobial Activity and Action Mechanism of Thymoquinone Against Bacillus Cereus and Its Spores

Identification of a Small Molecule 0390 As a Potent Antimicrobial Agent to Combat Antibiotic-Resistant Escherichia Coli

Mechanism of Synergy Between Tetracycline and Quercetin Against Antibiotic Resistant Escherichia coli

Antibacterial and Bactericide Activity of Lactic Acid Against Three Strains of Food-Borne Pathogenic Bacteria

Antibacterial effects and mechanisms of quercetin-β-cyclodextrin complex mediated photodynamic on Escherichia coli O157:H7

Improving Coenzyme Q 8 Production in Escherichia Coli Employing Multiple Strategies

Novel quorum sensing inhibitor Echinatin as an antibacterial synergist against Escherichia coli